Study Title | Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma |
---|---|
Protocol ID | ANBL1232 |
Disease (Sub Disease) | Ganglioneuroblastoma Neuroblastoma |
Diagnosis Stage | Relapse/refractory |
Location | NSW / QLD / WA / SA / NZ |
Sponsor | Children's Oncology Group |
Collaborators | National Cancer Institute (NCI) |
Links | https://clinicaltrials.gov/ct2/show/NCT02176967 |
Trial Status | Open |
Trial Open Date | 28/07/2014 |
Sites | The Children's Hospital at Westmead / John Hunter Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Women's & Children's Hospital / Christchurch Hospital / Starship Hospital |
Study Type | Treatment |
Phase | Phase 3 |
Age Eligibility | up to 18 months |
International registry ID's | NCT02176967 |